New findings highlighted a concerning trend in the discontinuation rates of Glucagon-like peptide-1 receptor agonists among patients with type 2 diabetes and obesity.

According to recent findings, social determinants of health significantly influence diabetic retinopathy care.

I think the most important thing to say in respect to this is that EHA is a members’ association, and as such, it’s crucial that we cater…

Hear from four pharma leaders on the benefits to employees and patients of workplaces that promote inclusivity for the LGBTQ+ community.

Findings from a comprehensive nationwide cohort study from Denmark have demonstrated the safety of paternal valproate use during spermatogenesis.

New findings show that postoperative prescription of a long-acting progestogen, or the combined oral contraceptive pill, can reduce the recurrence of endometriosis-related pain.

New research shows that integrating precision genomic testing with targeted therapies improves treatment responses and progression-free survival in pediatric oncology.

An algorithm-based default referrals system has led to a fourfold increase in the use of specialty palliative care within a large community oncology network.

Significant cardiovascular risks associated with adding androgen receptor signalling inhibitors to standard androgen deprivation therapy in patients with advanced prostate cancer.